Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Pregnancy Testing Market By Product, By Test Type Test, Human Chorionic Gonadotropin Hormone Blood Test, Urine Test, Luteinizing Hormone Test), By Distribution Channel,, and By Geography
Pregnancy Testing Market size was valued at US$ 1260 million in 2023 and is poised to grow at a CAGR of 5.14% from 2024-2030. Pregnancy testing kits are used for early detection of pregnancy. Home pregnancy tests are simple and easy to use, inexpensive, and provide accurate results within minutes. Most of the pregnancy tests are being taken in the home provided. The resulting accuracy is up to 97% to 99% when they are used as per the instructions. A urine pregnancy kit will be used for the detection of HCG hormone, a hormone which is only produced in the body of the pregnant woman. HCG production will be increased in the initial days of the pregnancy which will be doubled every 2-3 days in blood. The presence of HCG above a specific range will confirm pregnancy. Several prominent factors increase the demand for pregnancy test kits such as increasing disposable income, adoption of technological development for detecting pregnancy, and growing healthcare expenditure.
However, a lack of technical proficiency in a woman is a major restraining factor. Increasing demand for easy ways to obtain faster results and easily attainable pregnancy kits in online stores and pharmacy stores leads to the increase in demand for pregnancy test kits. Dip-strip tests that are simple to use and highly accurate can be acquired for less than ten cents from manufacturers. Furthermore, the Pregnancy Testing Market are not widely available in low-income nations, and a lack of awareness, combined with a low literacy rate among women, further inhibits the sale of pregnancy test kits in these countries. As a result, problems such as a lack of awareness and the lack of availability of pregnancy test kits are anticipated to stymie the market's expansion.
Study Period
2024-2030Base Year
2023CAGR
5.14%Largest Market
North AmericaFastest Growing Market
Asia Pacific
A surge in the number of unintended pregnancies increased awareness among women is expected to offer enormous growth opportunities for the market players. According to World Health Organization statistics, in 2015 over 40% of the pregnancy cases which are reporting every year are unintended & about 10% of the pregnancy cases were of teenage. A rise in the number of unintended pregnancies is expected to create demand for pregnancy test kits. Moreover, increasing promotional campaigns undertaken by the manufacturers like celebrity endorsing in order to influence the rural people about utilization of the pregnancy detection devices is expected to bolster pregnancy testing market growth. The market is growing due to reasons like 99% accuracy rate in identifying HCG levels from the day of an expected period of the women. Manufacturers are focussing on the new product launches, market expansions, mergers, acquisitions and collaborations which are also showing positive influence on the growth of the market.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 1260 million |
Market CAGR |
5.14% |
By Product |
|
By Test Type |
|
By Distribution Channel |
|
Download Free Sample Report
The pregnancy testing market size was valued at US$ 1260 million in 2023
The pregnancy testing market key players are Procter & Gamble Co (U.S.) Alere Inc. (U.S.) Church & Dwight (U.S.) Germaine Laboratories (U.S.) SPD Swiss Precision Diagnostics (Switzerland) Â Piramal Enterprises (India), Abbott Laboratories (U.S.) DCC plc (Ireland) Cardinal Health (U.S.) Prestige Brands Holdings (U.S.)
The pregnancy testing market drivers are increase in unplanned pregnancies
1.Executive Summary |
2.Global Pregnancy Testing Market Introduction |
2.1.Global Pregnancy Testing Market - Taxonomy |
2.2.Global Pregnancy Testing Market - Definitions |
2.2.1.Product Type |
2.2.2.Test Type |
2.2.3.Distribution Channel |
2.2.4.Region |
3.Global Pregnancy Testing Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Pregnancy Testing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Pregnancy Testing Market By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Pregnancy Rapid Test Kits |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Fertility Rapid Test |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6.Global Pregnancy Testing Market By Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Follicle Stimulating Hormone (FSH) Test |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Human Chorionic Gonadotropin Hormone Blood Test |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Urine Test |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Luteinizing Hormone (LH) Test |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7.Global Pregnancy Testing Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospital Pharmacies |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Retail Pharmacies |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Online Pharmacies |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Gynaecology Clinics |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Hypermarkets or Supermarkets |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.Global Pregnancy Testing Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Pregnancy Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Pregnancy Rapid Test Kits |
9.1.2.Fertility Rapid Test |
9.2. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Follicle Stimulating Hormone (FSH) Test |
9.2.2.Human Chorionic Gonadotropin Hormone Blood Test |
9.2.3.Urine Test |
9.2.4.Luteinizing Hormone (LH) Test |
9.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospital Pharmacies |
9.3.2.Retail Pharmacies |
9.3.3.Online Pharmacies |
9.3.4.Gynaecology Clinics |
9.3.5.Hypermarkets or Supermarkets |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Pregnancy Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Pregnancy Rapid Test Kits |
10.1.2.Fertility Rapid Test |
10.2. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Follicle Stimulating Hormone (FSH) Test |
10.2.2.Human Chorionic Gonadotropin Hormone Blood Test |
10.2.3.Urine Test |
10.2.4.Luteinizing Hormone (LH) Test |
10.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospital Pharmacies |
10.3.2.Retail Pharmacies |
10.3.3.Online Pharmacies |
10.3.4.Gynaecology Clinics |
10.3.5.Hypermarkets or Supermarkets |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) Pregnancy Testing Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Pregnancy Rapid Test Kits |
11.1.2.Fertility Rapid Test |
11.2. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Follicle Stimulating Hormone (FSH) Test |
11.2.2.Human Chorionic Gonadotropin Hormone Blood Test |
11.2.3.Urine Test |
11.2.4.Luteinizing Hormone (LH) Test |
11.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospital Pharmacies |
11.3.2.Retail Pharmacies |
11.3.3.Online Pharmacies |
11.3.4.Gynaecology Clinics |
11.3.5.Hypermarkets or Supermarkets |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Pregnancy Testing Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Pregnancy Rapid Test Kits |
12.1.2.Fertility Rapid Test |
12.2. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Follicle Stimulating Hormone (FSH) Test |
12.2.2.Human Chorionic Gonadotropin Hormone Blood Test |
12.2.3.Urine Test |
12.2.4.Luteinizing Hormone (LH) Test |
12.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospital Pharmacies |
12.3.2.Retail Pharmacies |
12.3.3.Online Pharmacies |
12.3.4.Gynaecology Clinics |
12.3.5.Hypermarkets or Supermarkets |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Pregnancy Testing Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Pregnancy Rapid Test Kits |
13.1.2.Fertility Rapid Test |
13.2. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Follicle Stimulating Hormone (FSH) Test |
13.2.2.Human Chorionic Gonadotropin Hormone Blood Test |
13.2.3.Urine Test |
13.2.4.Luteinizing Hormone (LH) Test |
13.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospital Pharmacies |
13.3.2.Retail Pharmacies |
13.3.3.Online Pharmacies |
13.3.4.Gynaecology Clinics |
13.3.5.Hypermarkets or Supermarkets |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Procter & Gamble Co (U.S.) |
14.2.2.Alere Inc. (U.S.) |
14.2.3.Church & Dwight (U.S.) |
14.2.4.Germaine Laboratories (U.S.) |
14.2.5.SPD Swiss Precision Diagnostics (Switzerland) |
14.2.6.Piramal Enterprises (India), |
14.2.7.Abbott Laboratories (U.S.) |
14.2.8.DCC plc (Ireland) |
14.2.9.Cardinal Health (U.S.) |
14.2.10.Prestige Brands Holdings (U.S.) |
14.2.11.Kent Pharmaceuticals (UK) |
14.2.12.Quidel Corporation (U.S.). |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players